Finnish questionnaire reasonably good predictor of the incidence of diabetes in the Netherlands;Finse vragenlijst redelijk goede voorspeller van het optreden van diabetes in Nederland

Nederlands Tijdschrift voor Geneeskunde

Volumn 152, Issue 44, 2008, Pages 2418-2424

  Alssema, M ^a   Feskens, E J M ^b   Bakker, S J L ^c   Gansevoort, R T ^c   Boer, J M A ^d   Heine, R J ^a   Nijpels, G ^a   Stehouwer, C D A ^e   Van Der Kraan, M ^f   Dekker, J M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^f Dutch Diabetes Research Foundation   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ARTICLE; DESCRIPTIVE RESEARCH; DIABETES MELLITUS; FINNISH QUESTIONNAIRE; INCIDENCE; NETHERLANDS; PREDICTION; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; VALIDITY;

ADULT; AGED; BODY MASS INDEX; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NETHERLANDS; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; WAIST-HIP RATIO;

EID: 55849153177     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Lindström J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemiö K, et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet. 2006;368:1673-9.
2. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403.
3. Chiasson IL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. STOP-NIDDM Trial Research Group. Lancet. 2002;359:2072-7.
4. Lindström J, Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care. 2003;26:725-31.
5. Bergmann A, Li J, Wang L, Schulze J, Bornstein SR, Schwarz PE. A simplified Finnish diabetes risk score to predict type 2 diabetes risk and disease evolution in a German population. Horm Metab Res. 2007;39:677-82.
6. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Report of a WHO/IDF consultation. Genève: WHO; 2006.
7. Franciosi M, de Berardis G, Rossi MC, Sacco M, Belfiglio M, Pellegrini F, et al. Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance: the IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) study. Diabetes Care. 2005;28:1187-94.
8. Saaristo T, Peltonen M, Lindström J, Saarikoski L, Sundvall J, Eriksson IG, et al. Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome. Diab Vasc Dis Res. 2005;2:67-72.
9. Mooy JM, Grootenhuis PA, Vries H de, Valkenburg HA, Bouter LM, Kostense PJ, et al. Prevalence and determinants of glucose intolerance in a Dutch Caucasian population. The Hoorn Study. Diabetes Care. 1995;18:1270-3.
10. Vegt F de, Dekker JM, Jager A, Hienkens E, Kostense PJ, Stehouwer CD, et al. Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: the Hoorn Study. JAMA. 2001;285:2109-13.
11. Pinto-Sietsma SJ, Janssen WM, Hillege HL, Navis G, Zeeuw D de, Jong PE de. Urinary albumin excretion is associated with renal functional abnormalities in a nondiabetic population. J Am Soc Nephrol. 2000;11:1882-8.
12. Verhave JC, Hillege HL, Burgerhof JG, Gansevoort RT, Zeeuw D de, Jong PE de. The association between atherosclerotic risk factors and renal function in the general population. PREVEND Study Group. Kidney Int. 2005;67:1967-73.
13. Dam RM van, Boer JM, Feskens EJ, Seidell JC. Parental history of diabetes modifies the association between abdominal adiposity and hyperglycemia. Diabetes Care. 2001;24:1454-9.
14. Mensink M, Corpeleijn E, Feskens EJ, Kruijshoop M, Saris WH, Bruin TW de, et al. Study on lifestyle-intervention and impaired glucose tolerance Maastricht (SLIM): design and screening results. Diabetes Res Clin Pract. 2003;61:49-58.
15. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29-36.
16. Visser M. Dwalingen in de methodologie. XXXIV. Predictiemodellen stellen vaak teleur. Ned Tijdschr Geneeskd. 2001;145:1109-12.
17. Bouter LM, Dongen MCIM van. Epidemiologisch onderzoek. Opzet en interpretatie. 4e herz dr. Houten: Bohn Stafleu van Loghum: 2000.
18. Rutten G, Grauw W de, Nijpels G, Goudswaard A, Uitewaal P, Does F van der, et al. NHG-standaard Diabetes mellitus type 2. 2e herziening. Huisarts Wet. 2006;49:137-52.
19. Burgers JS, Simoons ML, Hoes AW, Stehouwer CDA, Stalman WA. Richtlijn 'cardiovasculair risicomanagement'. Ned Tijdschr Geneeskd. 2007;151:1068-74.
20. Lindström I, Peltonen M, Eriksson JG, Aunola S, Hämä läinen H, Ilanne-Parikka P, et al. Determinants for the effectiveness of lifestyle intervention in the Finnish Diabetes Prevention Study. Diabetes Care. 2008;31:857-62.